Compare GSK plc (GSK) vs First Trust NASDAQ 100 Technology Index Fund (QTEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs First Trust NASDAQ 100 Technology Index Fund — how do they compare? GSK plc trades at $46.5 (market cap $91.88B), while First Trust NASDAQ 100 Technology Index Fund trades at $331.55 (market cap $4.10B). The key difference: GSK plc is far larger — about 22.4× First Trust NASDAQ 100 Technology Index Fund's market cap, and GSK plc pays a 3.9% dividend while First Trust NASDAQ 100 Technology Index Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and First Trust NASDAQ 100 Technology Index Fund for 40 Days on average.
| GSK | QTEC | |
|---|---|---|
Market Cap | $91.88B | $4.10B |
Volume | 7,730,529 | 264,303 |
Sector | Health | Broad Market / Factor |
52-Week High | $61.18 | $340.28 |
52-Week Low | $43.24 | $207.03 |
Typical Hold Time | 93 Days | 40 Days |
Enterprise Value | $111.88B | — |
Dividend Yield | 3.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.54, down 1.02% with bearish technical signals but strong fundamentals including 29.73% ROE and consistent earnings beats. The company maintains robust profitability with 72.73% gross margins and is actively expanding its oncology pipeline through strategic partnerships. Recent developments include a $750M cancer therapy acquisition and advancing mRNA vaccine candidates.
GSK presents a mixed outlook with strong operational performance offset by technical weakness. Investment appeal lies in valuation multiples below industry averages and pipeline expansion, though risks include HIV patent expirations and manufacturing restructuring. Analyst consensus leans cautious with 55% hold ratings amid near-term headwinds.
QTEC, the First Trust NASDAQ-100-Technology Sector ETF, trades at $329.21, down 1.97% today. Technical indicators show a bullish trend with moving averages supporting a buy signal, while oscillators are neutral. The ETF provides equal-weighted exposure to technology stocks, with recent analysis highlighting software industry undervaluation compared to historical averages.
The ETF's outlook is supported by broad tech sector exposure and liquidity advantages over peers, but risks include market volatility and sector-specific headwinds. Investor sentiment remains mixed, with technical strength offset by neutral momentum indicators, suggesting cautious optimism for tech-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About First Trust NASDAQ 100 Technology Index Fund
QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Read more on QTEC →
